| __timestamp | Celldex Therapeutics, Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 1595000 |
| Thursday, January 1, 2015 | 100171000 | 11434000 |
| Friday, January 1, 2016 | 102726000 | 26546000 |
| Sunday, January 1, 2017 | 96171000 | 39778000 |
| Monday, January 1, 2018 | 66449000 | 53418000 |
| Tuesday, January 1, 2019 | 42672000 | 111997000 |
| Wednesday, January 1, 2020 | 42534000 | 139507000 |
| Friday, January 1, 2021 | 53311000 | 195958000 |
| Saturday, January 1, 2022 | 82258000 | 248149000 |
| Sunday, January 1, 2023 | 118011000 | 232366000 |
Infusing magic into the data realm
In the ever-evolving world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, ImmunityBio, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. From 2014 to 2023, ImmunityBio's R&D expenses surged by an impressive 14,500%, peaking in 2022 with a 248% increase compared to 2018. This reflects their aggressive pursuit of cutting-edge therapies. Meanwhile, Celldex's R&D spending showed a more conservative trajectory, with a 60% decrease from 2014 to 2019, before rebounding by 177% in 2023. This fluctuation highlights their strategic recalibration in response to market dynamics. As these companies navigate the competitive biotech landscape, their R&D investments will continue to shape their innovation potential and market positioning.
Comparing Innovation Spending: Johnson & Johnson and ImmunityBio, Inc.
Analyzing R&D Budgets: Merck & Co., Inc. vs Celldex Therapeutics, Inc.
Research and Development Investment: Amgen Inc. vs Celldex Therapeutics, Inc.
Zoetis Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
argenx SE or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
R&D Insights: How Halozyme Therapeutics, Inc. and ImmunityBio, Inc. Allocate Funds
R&D Insights: How Lantheus Holdings, Inc. and ImmunityBio, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Perrigo Company plc or ImmunityBio, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and MiMedx Group, Inc.